Reliability of Sentinel Lymph Node Mapping With Biopsy for Head and Neck Cutaneous Melanoma

Authors:
  • BNBrian Nussenbaum
    Brian Nussenbaum
  • RRRiley S. Rees
    Riley S. Rees
  • JSJennifer Schwartz
    Jennifer Schwartz
  • TJTimothy M. Johnson
    Timothy M. Johnson

Abstract
NUMEROUS QUESTIONS surround the management of head and neck cutaneous melanoma, especially with respect to the role for elective treatment of regional nodal basins. Prospective randomized trials have failed to demonstrate a survival benefit for patients with melanoma undergoing elective lymphadenectomy.1,2 While nodal status is clearly recognized as the most significant prognostic factor for patients diagnosed with cutaneous melanoma, only 10% to 20% of patients present with occult lymph node metastasis. This risk for nodal metastasis increases as primary tumor thickness increases. Lesions less than 1 mm thick are associated with a less than 5% rate of regional metastasis, while lesions thicker than 4 mm are associated with a 30% to 50% rate of nodal involvement.3,4

This publication has 24 references indexed in Scilit: